Vol 5 No 10 (2019): International Journal For Research In Biology & Pharmacy (ISSN: 2208-2093)
Articles

Adénocarcinome villoglandulaire du col utérin : à propos d’un cas et revue de la littérature

Fenohery Nalisoa RAKOTONDRAINIBE
Pathology Laboratory of University Hospital Anosiala Ambohidratrimo, Antananarivo, Madagascar
Haingo Voahangy Rabetafika RANAIVOSON
Pathology Department of Joseph Ravoahangy Andrianavalona University Hospital, Antanananarivo, Madagascar
Lalaoarifetra Andriamampihantona RAMIANDRASOA
Pathology Department of Sampan’Asa Loterana momba ny FAhasalamana, Antanananarivo, Madagascar
Nantenaina Soa RANDRIANJAFISAMINDRAKOTROKA
Pathology Department of Joseph Ravoahangy Andrianavalona University Hospital, Antanananarivo, Madagascar
RAIVOHERIVONY Zo Irène
Pathology Department of Joseph Ravoahangy Andrianavalona University Hospital, Antanananarivo, Madagascar
Published October 31, 2019
Keywords
  • Cancer; Cervix uteri; Pathology; Villoglandular adenocarcinoma
How to Cite
RAKOTONDRAINIBE, F. N., RANAIVOSON, H. V. R., RAMIANDRASOA, L. A., RANDRIANJAFISAMINDRAKOTROKA, N. S., & RAIVOHERIVONY Zo Irène. (2019). Adénocarcinome villoglandulaire du col utérin : à propos d’un cas et revue de la littérature . International Journal For Research In Biology & Pharmacy (ISSN: 2208-2093), 5(10), 01-04. Retrieved from https://gnpublication.org/index.php/bp/article/view/1149

Abstract

We report the case of a 42-year-old woman with metrorrhagia. The physical examination revealed an exophytic, friable mass with endocervical development. It affirmed the diagnosis of villoglandular adenocarcinoma of the cervix.

Downloads

Download data is not yet available.

References

REFERENCES
[1] Young RH, Scully RE. Villoglandular papillary adenocarcinoma of the uterine cervix.A clinicopathologic analysis of 13 cases.Cancer.1989; 63:1773-9.
[2] M. Wells, A.G. Ostor, C.P. Crum, etal.Tumors of the cervix. F.A. Tavassoli, P. Devilee (Eds.), Tumors of the Breast and Female Genital Organs, IARC Press, Lyon, France (2003), pp. 262-276
[3] Wang SS, Sherman ME, Silverberg SG, Carreon JD, Lacey JV Jr, Zaino R, Kurman RJ, Hildesheim A: Pathological characteristics of cervical adenocarcinoma in a multi-center US-based study. GynecolOncol 2006, (103):541–6.
[4] Yamazawa K, Matsui H, Seki K, et al. Human papillomavirus-positive welldifferentiated villoglandular adenocarcinoma of the uterine cervix: a case report and review of the literature. GynecolOncol. 2000; 77: 473-7
[5] Lataifeh I M, Al-Hussaini M, Uzan C, ImadJaradat I, Duvillard P, Morice P. Villoglandular papillary adenocarcinoma of the cervix: a series of 28 cases including two with lymph node metastasis.Int J Gynecol Cancer. 2013; 23 (5) 900-5.
[6] Zhou Q Y, Chen H Y, Yang S M, Li Y H, Wu X Q. Villoglandular papillary adenocarcinoma of the uterine cervix: A report of 4 cases and a review of the literature.Oncol Lett. 2016; 11 (1): 837-41.
[7] Macdonald RD, Kirwan J, Hayat K, Herrington CS, Shawki H. Villoglandular adenocarcinoma of the cervix: clarity is needed on the histological definition for this difficult diagnosis. GynecolOncol. 2006;100(1):192–4.
[8] Costa MJ, McIlnay KR, Trelford J. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients. Hum Pathol. 1995;26(8):829–837.
[9] Young R H, Clement P B. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology. 2002, 41, 185–207
[10] Jones MW, Kounelis S, Papadaki H, et al. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping. Int J Gynecol Pathol. 2000;19 (2):110–107.
[11] Maneo A, Chiari S, Bonazzi C, Mangioni C. Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer. Gynecol Oncol. 2008;111(3):438–443.